Authors

Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopia

Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation

Outcomes of post-SMILE Cataract Surgery with Multifocal IOL Implantation: The Benefit of Total Keratometry for Power Calculation

Successful presbyopia correction after hyperopic LASIK using the AT LARA EDoF IOL

Restoring near and intermediate vision with corneal excimer laser surgery

AI-powered Eye2Gene uses multimodal imaging to diagnose inherited retinal disease

The platform, developed by University College London and Heidelberg Engineering, demonstrated accuracy and precision in early tests

Making the transition to SMILE has benefited my patients and my practice

Clinicians keep their eyes on wartime ocular trauma

Every day brings a new challenge for surgeons in low-resource areas and conflict zones

PRESBYOND Laser Blended Vision from ZEISS – the procedure for compensating presbyopia

Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approach

In this insightful analysis, Dr. Joong Hun Kim presents real-world clinical outcomes with bilateral implantation of ZEISS AT ELANA 841P. Dr. Kim recommends AT ELANA® 841P as an excellent option for patients undergoing cataract surgery as its fully trifocal optical design translates into a full range of vision. He also introduces the so-called ‘ELISA’ approach for patients requiring astigmatic correction in one eye only, combining AT ELANA 841P and ZEISS AT LISA tri toric 939MP. Early objective and subjective clinical data from this novel approach reveal promising visual outcomes and high patient satisfaction

Presbyopic Commercial Airline Pilot Finds a Class One Medical Approved Corneal Refractive Surgery Solution for Presbyopia

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

SETTING A NEW STANDARD IN CATARACT SURGERY SAFETY

The ZEISS IOL Power Calculation Service. Providing guidance in complex cases

Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.

New wet AMD therapeutics seek to improve visual outcomes beyond the current standard of care

Breakthrough technologies are raising the ceiling for functional visual outcomes

To Infinity and (PRES)BYOND - The game changer for my practice

Lourens van Zyl wanted to set himself apart in a highly competitive surrounding and saw a potential for practice building by offering solutions for presbyopia in patients without cataract. Within a few years this group became a significant segment of his practice in total share. ZEISS PRESBYOND was the game changer for a business success story.

FLORetina 2025: Navigating antithrombotic therapy in wet AMD

Sharon Fekrat discusses the complexities of antithrombotic use in wet AMD, highlighting the need for individualized treatment and future guideline development.

Achieving spectacle independence with PRESBYOND Laser Blended Vision

The ZEISS IOL Power Calculation Service. Providing guidance in complex cases

Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.

Glaucoma specialists take back treatment compliance

Moving on from medication “stacks” and the old-school reactive approach

Providing spectacle independence for a young adult patient with cataract and astigmatism

Playing matchmaker with Schlemm canal surgery

Two glaucoma specialists discuss pairing patients with the right procedures